// COMPANY
Blackstone Life Sciences
// OVERVIEW
Life sciences investment arm of Blackstone that provided up to $1.3B in nondilutive funding to Apogee Therapeutics.
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·PitchBook News·MAY 29, 2026
“Blackstone Life Sciences agreed to invest up to $1.3 billion in Nasdaq-listed Apogee Therapeutics, which specializes in biologic drugs.”
Source→02
funding·Axios Pro Rata·MAY 27, 2026
“Blackstone Life Sciences led up to $1.3b in nondilutive funding to Apogee Therapeutics.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.